⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,704.92
+0.59%
Nasdaq 100
29,574.28
+1.33%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.00
+1.34%
NYSE:TSM
$420.82
+1.99%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,145.66
−0.47%
Brent
$109.59
−0.20%
BTC
$81,701.03
−0.38%
ETH
$2,388.34
−0.79%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,704.92
+0.59%
Nasdaq 100
29,574.28
+1.33%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.00
+1.34%
NYSE:TSM
$420.82
+1.99%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,145.66
−0.47%
Brent
$109.59
−0.20%
BTC
$81,701.03
−0.38%
ETH
$2,388.34
−0.79%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NYSE
› AZN
A
AstraZeneca PLC
NYSE:AZN
Healthcare
—
—
At close · Market cap
—
· Next earnings
Fri 30 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
AstraZeneca PLC · News · TradingHolo
AZN news
Headlines tagged to this company
SE
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro
Seeking Alpha · 4 d ago
SE
Hospital group files lawsuit to stop 340B rebate pilot again
Seeking Alpha · 9 d ago
SE
Myriad, SOPHiA partner with AstraZeneca to use prostate cancer technology
Seeking Alpha · 11 d ago
SE
AstraZeneca CEO Soriot says drugmaker can grow without big acquisition
Seeking Alpha · 14 d ago
BU
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
BusinessWire · 14 d ago
SE
Trending stocks this week as markets weigh jobs data, yields
Seeking Alpha · 15 d ago
SE
Catalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount
seekingalpha · 24 d ago
SE
AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma
seekingalpha · 26 d ago
SE
Novo CEO says Ozempic maker is open to direct U.S. listing: FT
seekingalpha · 26 d ago
SE
Merck, Astra, Roche and Corcept among winners of EU drug recommendations this week
seekingalpha · 31 d ago
GU
AstraZeneca Gains as Enhertu Clears England's Value Gate
gurufocus · 32 d ago
SE
Astra-Daiichi breast cancer drug Enhertu recommended for NHS use in England
seekingalpha · 32 d ago
SE
BlossomHill closes up 18% on strongest day since August IPO
seekingalpha · 33 d ago
GU
AstraZeneca Shares Rise as J.P. Morgan Stays Overweight
gurufocus · 33 d ago
MA
AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears
marketbeat · 36 d ago
SE
Olema drops after hours on AstraZeneca Etcamah data
seekingalpha · 38 d ago
SE
AstraZeneca's Etcamah fails in late-stage trial as first-line breast cancer treatment
seekingalpha · 38 d ago
GU
AstraZeneca Falls 1.3% Despite a 34% COPD Breakthrough
gurufocus · 40 d ago
SE
Astra, Roche win new Outperform ratings as RBC initiates EU pharma coverage
seekingalpha · 40 d ago
GU
AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival Test
gurufocus · 41 d ago
More news →